The 24 analysts offering 12-month price forecasts for Amgen Inc have a median target of 265.00, with a high estimate of 301.00 and a low estimate of 185.00. The median estimate represents a +3.63% increase from the last price of 255.72.
The current consensus among 29 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.04
Reporting Date Apr 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.